• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Whistle-blowers' experiences in fraud litigation against pharmaceutical companies.

作者信息

Kesselheim Aaron S, Studdert David M, Mello Michelle M

机构信息

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, USA.

出版信息

N Engl J Med. 2010 May 13;362(19):1832-9. doi: 10.1056/NEJMsr0912039.

DOI:10.1056/NEJMsr0912039
PMID:20463344
Abstract
摘要

相似文献

1
Whistle-blowers' experiences in fraud litigation against pharmaceutical companies.举报人在针对制药公司的欺诈诉讼中的经历。
N Engl J Med. 2010 May 13;362(19):1832-9. doi: 10.1056/NEJMsr0912039.
2
Blowing the whistle on healthcare fraud: should I?揭发医疗欺诈行为：我应该这么做吗？
J Am Acad Nurse Pract. 2006 Nov;18(11):512-7. doi: 10.1111/j.1745-7599.2006.00175.x.
3
Don't be afraid to blow the whistle.
Adv Nurse Pract. 2001 Nov;9(11):21.
4
Whistleblowing in the pharmaceutical industry in the United States, England, Canada, and Australia.美国、英国、加拿大和澳大利亚制药行业的举报行为。
J Public Health Policy. 2010 Apr;31(1):17-29. doi: 10.1057/jphp.2009.51.
5
Punishing health care fraud--is the GSK settlement sufficient?惩治医疗保健欺诈行为——葛兰素史克公司的和解协议是否足够？
N Engl J Med. 2012 Sep 20;367(12):1082-5. doi: 10.1056/NEJMp1209249. Epub 2012 Sep 12.
6
Doctor explains why he blew the whistle.
N Y Times Web. 2003 Mar 12:C1, C2.
7
How to respond to a qui tam lawsuit.如何应对qui tam诉讼。
Trustee. 2004 Sep;57(8):12-4, 19, 1.
8
The unusual suspects. Whistle-blowers target contractor, Bear Stearns.不寻常的嫌犯。举报人将矛头指向承包商贝尔斯登。
Mod Healthc. 2004 Jul 5;34(27):14-5.
9
Whistle-blower tactic. Lawsuits shouldn't use public sources: groups.举报人策略。团体称诉讼不应使用公开来源。
Mod Healthc. 2009 Sep 14;39(37):8-9.
10
Invited commentary: The whistle-blower act (qui tam).特邀评论：举报人法案（qui tam）
Surgery. 2005 Apr;137(4):472-6. doi: 10.1016/j.surg.2004.12.005.

引用本文的文献

1
Reward whistleblowers who expose environmental crimes.奖励揭发环境犯罪行为的举报人。
Nat Hum Behav. 2024 Mar;8(3):404-405. doi: 10.1038/s41562-024-01825-8.
2
The Public's Self-Avoidance and Other-Reliance in the Reporting of Medical Insurance Fraud: A Cross-Sectional Survey in China.公众在医疗保险欺诈举报中的自我回避与依赖他人：一项中国的横断面调查
Risk Manag Healthc Policy. 2023 Dec 22;16:2869-2881. doi: 10.2147/RMHP.S438854. eCollection 2023.
3
Why Not Blow the Whistle on Health Care Insurance Fraud? Evidence from Jiangsu Province, China.
为何不揭发医疗保险欺诈行为？来自中国江苏省的证据。
Risk Manag Healthc Policy. 2022 Oct 12;15:1897-1915. doi: 10.2147/RMHP.S379300. eCollection 2022.
4
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions.医学警示：临床医生在发表严重肿瘤相关药物不良反应报告方面的经验。
PLoS One. 2019 Jul 31;14(7):e0219521. doi: 10.1371/journal.pone.0219521. eCollection 2019.
5
Combatting Antibiotic Resistance Together: How Can We Enlist the Help of Industry?共同应对抗生素耐药性：我们如何获得制药行业的帮助？
Antibiotics (Basel). 2018 Dec 18;7(4):111. doi: 10.3390/antibiotics7040111.
6
Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.制药行业的药品未按批准说明书用药推广与自我监管：对英国药品使用规范管理局2003 - 2012年未按批准说明书用药推广裁决的文件分析
PLoS Med. 2016 Jan 26;13(1):e1001945. doi: 10.1371/journal.pmed.1001945. eCollection 2016 Jan.
7
A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan.日本新型及新兴药物的获益-风险评估视角
Drug Des Devel Ther. 2015 Mar 31;9:1877-88. doi: 10.2147/DDDT.S62636. eCollection 2015.
8
Off-label use of atypical antipsychotics: cause for concern?非适应证使用非典型抗精神病药物：值得关注吗？
CNS Drugs. 2012 May 1;26(5):383-90. doi: 10.2165/11632030-000000000-00000.
9
Embedding 'speaking up' into systems for safe healthcare product development and marketing surveillance.将“发声”嵌入安全医疗产品开发和市场监测系统。
Drug Saf. 2012 Apr 1;35(4):265-71. doi: 10.2165/11597860-000000000-00000.
10
Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaints.药品标签外营销的策略和实践：告密者投诉的回顾性分析。
PLoS Med. 2011 Apr;8(4):e1000431. doi: 10.1371/journal.pmed.1000431. Epub 2011 Apr 5.